Clinical studies recruiting near Tucson

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · The University of Arizona Cancer Center - North Campus · Eli Lilly and Company · NCT07218380 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Banner University Medical Center - Tucson · National Cancer Institute (NCI) · NCT05564390 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site - 7067 · Galderma R&D · NCT06988605 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Banner University Medical Center - Tucson · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Banner University Medical Center - Tucson · NRG Oncology · NCT05624996 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · Arizona Urology Specialists · SURGE Therapeutics · NCT05710848 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, A · Takeda · NCT06671496 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Banner University Medical Center - Tucson · National Cancer Institute (NCI) · NCT05691478 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · The University of Arizona Cancer Center · Clasp Therapeutics, Inc. · NCT06778863 Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Arizona Urology Specialists · Olympus Corporation of the Americas · NCT04757116 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · The University of Arizona Cancer Center - North Campus · Eli Lilly and Company · NCT06890598 Native Spirit: Significant Aim 3: Intervention
NA · Pascua Yaqui Tribe Boys & Girls Club · Arizona State University · NCT06785311 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Arizona Oncology Associates, PC - HOPE · Agendia · NCT03053193 Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
Phase 1/Phase 2 · University of Arizona · University of Arizona · NCT06282965 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 8400024 · Sanofi · NCT06958536 FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Arizona Cancer Center at University of Arizona · Parabilis Medicines, Inc. · NCT05919264 Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
NA · University of Arizona · Innova Vascular, Inc. · NCT06041594 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Banner University Medical Center - Tucson · Children's Oncology Group · NCT04322318 Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Phase 2 · Arizona Oncology Associates · SCRI Development Innovations, LLC · NCT05972135 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · The University of Arizona Cancer Center - North Campus ( Sit · Merck Sharp & Dohme LLC · NCT06077760 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Arizona Urology Specialty · CG Oncology, Inc. · NCT06567743 Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Phase 3 · University of Arizona · Philip Spinella · NCT06070350 4-aminopyridine Treatment for Nerve Injury
Phase 2/Phase 3 · University of Arizona · John Elfar · NCT03701581 4D-710 in Adult Patients With Cystic Fibrosis
Phase 2 · The University of Arizona · 4D Molecular Therapeutics · NCT05248230 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Banner University Medical Center - Tucson · NRG Oncology · NCT05174169 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Tucson Orthopaedic Institute - North Wyatt Drive · Eli Lilly and Company · NCT07353931 Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss
NA · The University of Arizona Hearing Clinic · University of Arizona · NCT07228845 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 12104 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Banner University Medical Center - Tucson · Alliance for Clinical Trials in Oncology · NCT06931340

Look up another city

Look up another condition